Can a new IV antiviral tame two stubborn viruses?
Disease control
Completed
This trial is testing an experimental drug called brincidofovir, given intravenously, in people aged 2 months and older who have an adenovirus or cytomegalovirus infection. The study aims to see how safe and tolerable different doses are, and whether the drug can reduce the amoun…
Phase 2 • Sponsor: SymBio Pharmaceuticals • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC